T1	p 1105 1267	surgical patients including those undergoing noncardiac thoracic and pelvic operations who were identified at moderate to high risk for postop DVT were included .
T2	p 1445 1563	positive . Eight hundred and eighty eight patients were entered into this trial and 744 ( 85 % ) completed the study .
T3	i 547 584	dihydroergotamine ( DHE ) and heparin
T4	i 1087 1113	placebo . General surgical
T5	i 1645 1652	placebo